Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind placebo-controlled study of Yanshao Lidan Tablets in chronic calculous cholecystitis
CTR20220457Phase 2Active
- Sponsor
- Hunan Zhongjia Pharmaceutical Development
- Start
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Yanshao Lidan in Chronic calculous cholecystitis (CCC), sponsored by Hunan Zhongjia Pharmaceutical Development. Started Jul 2022; status: active.
02
Drugs
Yanshao Lidan
03
Conditions
Chronic calculous cholecystitis (CCC)
Beyond the preview
Go deeper on CTR20220457.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20220457.